Listing 1 - 7 of 7 |
Sort by
|
Choose an application
Cholera --- Hantavirus infections --- Herpesvirus, kaposi sarcoma-associated --- Leptospirosis --- Malaria --- Plague --- Prion diseases --- Yellow fever virus
Choose an application
(will follow).
Kaposi's sarcoma. --- Herpesvirus diseases. --- Herpes --- Herpesvirus infections --- Virus diseases --- Idiopathic hemorrhagic sarcoma --- Kaposi sarcoma --- KS (Kaposi's sarcoma) --- Multiple hemorrhagic sarcoma --- Sarcoma --- Medical virology. --- Virology. --- Medical microbiology --- Virology --- Microbiology
Choose an application
Tumor Virus Infections. --- Herpesvirus 4, Human. --- Herpesvirus 8, Human. --- Herpesviridae Infections --- Lymphoma --- Nasopharyngeal Neoplasms --- Risk Assessment. --- HHV-8 --- Herpesvirus, Kaposi's Sarcoma-Associated --- Human Herpesvirus 8 --- Kaposi's Sarcoma-Associated Herpesvirus --- Herpesvirus, Kaposi Sarcoma-Associated --- KSHV --- Kaposi Sarcoma-Associated Herpesvirus --- Herpesvirus, Kaposi Sarcoma Associated --- Herpesvirus, Kaposi's Sarcoma Associated --- Herpesvirus, Kaposis Sarcoma-Associated --- Herpesviruses, Kaposi's Sarcoma-Associated --- Kaposi Sarcoma Associated Herpesvirus --- Kaposi's Sarcoma Associated Herpesvirus --- Kaposi's Sarcoma-Associated Herpesviruses --- Kaposis Sarcoma-Associated Herpesvirus --- Sarcoma-Associated Herpesvirus, Kaposi --- Sarcoma-Associated Herpesviruses, Kaposi's --- Burkitt's Lymphoma Virus --- HHV-4 --- Herpesvirus 4 (gamma), Human --- Burkitt Herpesvirus --- Burkitt Lymphoma Virus --- E-B Virus --- EBV --- Epstein-Barr Virus --- Human Herpesvirus 4 --- Infectious Mononucleosis Virus --- Burkitts Lymphoma Virus --- E B Virus --- E-B Viruses --- Epstein Barr Virus --- Herpesvirus, Burkitt --- Infectious Mononucleosis Viruses --- Lymphoma Virus, Burkitt --- Mononucleosis Virus, Infectious --- Mononucleosis Viruses, Infectious --- Heatlh Risk Assessment --- Risks and Benefits --- Assessment, Risk --- Benefit-Risk Assessment --- Risk-Benefit Assessment --- Assessment, Benefit-Risk --- Assessment, Heatlh Risk --- Assessment, Risk-Benefit --- Assessments, Benefit-Risk --- Assessments, Heatlh Risk --- Assessments, Risk --- Assessments, Risk-Benefit --- Benefit Risk Assessment --- Benefit-Risk Assessments --- Benefits and Risks --- Heatlh Risk Assessments --- Risk Assessment, Heatlh --- Risk Assessments --- Risk Assessments, Heatlh --- Risk Benefit Assessment --- Risk-Benefit Assessments --- Infections, Tumor Virus --- Fibroma, Shope --- Papilloma, Shope --- Infection, Tumor Virus --- Shope Fibroma --- Shope Papilloma --- Tumor Virus Infection --- Neoplasms, Experimental --- Oncogenic Viruses --- complications. --- etiology. --- Conferences - Meetings --- Health Risk Assessment --- Assessment, Health Risk --- Assessments, Health Risk --- Health Risk Assessments --- Risk Assessment, Health --- Risk Assessments, Health --- Risk Analysis --- Analysis, Risk --- Risk Analyses --- Tumor Virus Infections --- Herpesvirus 4, Human --- Herpesvirus 8, Human --- Risk Assessment --- complications --- etiology --- Epstein-Barr virus. --- Kaposi's sarcoma. --- Carcinogens.
Choose an application
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.
Medicine --- NKG2D --- CAR T --- IL-7 --- prostate cancer --- cell therapy --- CD19-CAR-T --- B cell aplasia --- KIR --- PD-1 --- inhibitory CAR --- tumor-infiltrating lymphocytes --- tumor microenvironment --- immunotherapy --- NK cells --- cancer stem cells (CSCs) --- antibody-dependent cellular cytotoxicity (ADCC) --- differentiation --- cytotoxicity --- IFN-γ --- osteoclasts --- MICA/B mAb --- DNA methylation --- RNA methylation --- S-adenosylmethionine (SAM) --- cancer --- innate immunity --- adaptive immunity --- T cells --- m6A --- PD-L1 --- resistance --- immune checkpoints --- cancer vaccine --- combination immunotherapy --- TCR diversity --- organ transplantation --- carcinoma --- epidemiologic studies --- immunosuppression --- CTLA-4 --- Treg cells --- immune checkpoint inhibitors --- CD28 --- antigen-presenting cells --- IL15 --- colon cancer --- melanoma --- uveal --- BAP1 --- anti-PD-1 --- anti-CTLA-4 --- TIL --- classical and endemic Kaposi Sarcoma --- systemic treatment --- multi-state modelling --- treatment free interval --- chemotherapy --- interferon --- triple negative breast cancer --- immunomodulation --- bispecific antibody --- sortase A --- chemo-enzymatic approach --- anti-CD20 antibody --- Fab --- BiFab --- colorectal cancer --- dendritic cells --- Atypical Chemokine Receptor 4 (ACKR4) --- T-cell priming --- immune checkpoint blockade --- primary liver cancer --- kynurenine pathway --- immune evasion --- indoleamine 2,3 dioxygenase 1 --- tryptophan 2,3 dioxygenase 2 --- IDO inhibitor --- antigen presenting cells --- n/a
Choose an application
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.
NKG2D --- CAR T --- IL-7 --- prostate cancer --- cell therapy --- CD19-CAR-T --- B cell aplasia --- KIR --- PD-1 --- inhibitory CAR --- tumor-infiltrating lymphocytes --- tumor microenvironment --- immunotherapy --- NK cells --- cancer stem cells (CSCs) --- antibody-dependent cellular cytotoxicity (ADCC) --- differentiation --- cytotoxicity --- IFN-γ --- osteoclasts --- MICA/B mAb --- DNA methylation --- RNA methylation --- S-adenosylmethionine (SAM) --- cancer --- innate immunity --- adaptive immunity --- T cells --- m6A --- PD-L1 --- resistance --- immune checkpoints --- cancer vaccine --- combination immunotherapy --- TCR diversity --- organ transplantation --- carcinoma --- epidemiologic studies --- immunosuppression --- CTLA-4 --- Treg cells --- immune checkpoint inhibitors --- CD28 --- antigen-presenting cells --- IL15 --- colon cancer --- melanoma --- uveal --- BAP1 --- anti-PD-1 --- anti-CTLA-4 --- TIL --- classical and endemic Kaposi Sarcoma --- systemic treatment --- multi-state modelling --- treatment free interval --- chemotherapy --- interferon --- triple negative breast cancer --- immunomodulation --- bispecific antibody --- sortase A --- chemo-enzymatic approach --- anti-CD20 antibody --- Fab --- BiFab --- colorectal cancer --- dendritic cells --- Atypical Chemokine Receptor 4 (ACKR4) --- T-cell priming --- immune checkpoint blockade --- primary liver cancer --- kynurenine pathway --- immune evasion --- indoleamine 2,3 dioxygenase 1 --- tryptophan 2,3 dioxygenase 2 --- IDO inhibitor --- antigen presenting cells --- n/a
Choose an application
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.
Medicine --- NKG2D --- CAR T --- IL-7 --- prostate cancer --- cell therapy --- CD19-CAR-T --- B cell aplasia --- KIR --- PD-1 --- inhibitory CAR --- tumor-infiltrating lymphocytes --- tumor microenvironment --- immunotherapy --- NK cells --- cancer stem cells (CSCs) --- antibody-dependent cellular cytotoxicity (ADCC) --- differentiation --- cytotoxicity --- IFN-γ --- osteoclasts --- MICA/B mAb --- DNA methylation --- RNA methylation --- S-adenosylmethionine (SAM) --- cancer --- innate immunity --- adaptive immunity --- T cells --- m6A --- PD-L1 --- resistance --- immune checkpoints --- cancer vaccine --- combination immunotherapy --- TCR diversity --- organ transplantation --- carcinoma --- epidemiologic studies --- immunosuppression --- CTLA-4 --- Treg cells --- immune checkpoint inhibitors --- CD28 --- antigen-presenting cells --- IL15 --- colon cancer --- melanoma --- uveal --- BAP1 --- anti-PD-1 --- anti-CTLA-4 --- TIL --- classical and endemic Kaposi Sarcoma --- systemic treatment --- multi-state modelling --- treatment free interval --- chemotherapy --- interferon --- triple negative breast cancer --- immunomodulation --- bispecific antibody --- sortase A --- chemo-enzymatic approach --- anti-CD20 antibody --- Fab --- BiFab --- colorectal cancer --- dendritic cells --- Atypical Chemokine Receptor 4 (ACKR4) --- T-cell priming --- immune checkpoint blockade --- primary liver cancer --- kynurenine pathway --- immune evasion --- indoleamine 2,3 dioxygenase 1 --- tryptophan 2,3 dioxygenase 2 --- IDO inhibitor --- antigen presenting cells
Choose an application
Cancer --- Viral carcinogenesis --- Burkitt Lymphoma --- Hepatitis B virus --- Leukemia --- Liver Neoplasms --- Nasopharyngeal Neoplasms --- Penile Neoplasms --- Sarcoma, Kaposi --- Uterine Cervical Neoplasms --- Cancer of Cervix --- Cancer of the Cervix --- Cancer of the Uterine Cervix --- Cervical Cancer --- Cervical Neoplasms --- Cervix Cancer --- Cervix Neoplasms --- Neoplasms, Cervical --- Neoplasms, Cervix --- Uterine Cervical Cancer --- Cancer, Cervix --- Cancer, Uterine Cervical --- Cancers, Cervix --- Cancers, Uterine Cervical --- Cervical Cancer, Uterine --- Cervical Cancers, Uterine --- Cervical Neoplasm --- Cervical Neoplasm, Uterine --- Cervical Neoplasms, Uterine --- Cervix Neoplasm --- Neoplasm, Cervical --- Neoplasm, Cervix --- Neoplasm, Uterine Cervical --- Neoplasms, Uterine Cervical --- Uterine Cervical Cancers --- Uterine Cervical Neoplasm --- Uterine Cervical Dysplasia --- Cervical Intraepithelial Neoplasia --- Kaposi's Sarcoma --- Multiple Idiopathic Pigmented Hemangiosarcoma --- Kaposi Sarcoma --- Kaposis Sarcoma --- Sarcoma, Kaposi's --- Cancer of the Penis --- Neoplasms, Penile --- Neoplasms, Penis --- Penis Cancer --- Penis Neoplasms --- Cancer of Penis --- Penile Cancer --- Cancer, Penile --- Cancer, Penis --- Cancers, Penile --- Cancers, Penis --- Neoplasm, Penile --- Neoplasm, Penis --- Penile Cancers --- Penile Neoplasm --- Penis Cancers --- Penis Neoplasm --- Cancer of the Nasopharynx --- Nasopharynx Cancer --- Nasopharynx Neoplasms --- Neoplasms, Nasopharyngeal --- Cancer of Nasopharynx --- Nasopharyngeal Cancer --- Cancer, Nasopharyngeal --- Cancer, Nasopharynx --- Cancers, Nasopharyngeal --- Cancers, Nasopharynx --- Nasopharyngeal Cancers --- Nasopharyngeal Neoplasm --- Nasopharynx Cancers --- Nasopharynx Neoplasm --- Neoplasm, Nasopharyngeal --- Neoplasm, Nasopharynx --- Neoplasms, Nasopharynx --- Cancer of the Liver --- Cancer, Hepatocellular --- Hepatic Neoplasms --- Hepatocellular Cancer --- Neoplasms, Hepatic --- Neoplasms, Liver --- Cancer of Liver --- Hepatic Cancer --- Liver Cancer --- Cancer, Hepatic --- Cancer, Liver --- Cancers, Hepatic --- Cancers, Hepatocellular --- Cancers, Liver --- Hepatic Cancers --- Hepatic Neoplasm --- Hepatocellular Cancers --- Liver Cancers --- Liver Neoplasm --- Neoplasm, Hepatic --- Neoplasm, Liver --- Leucocythaemia --- Leucocythemia --- Leucocythaemias --- Leucocythemias --- Leukemias --- Myeloproliferative Disorders --- Hematologic Neoplasms --- Burkitt Leukemia --- Burkitt's Leukemia --- Burkitt's Lymphoma --- Burkitt's Tumor --- Leukemia, Lymphoblastic, Burkitt-Type --- Leukemia, Lymphocytic, L3 --- Lymphocytic Leukemia, L3 --- African Lymphoma --- Burkitt Cell Leukemia --- Burkitt Tumor --- Lymphoma, Burkitt --- Burkitts Leukemia --- Burkitts Lymphoma --- Burkitts Tumor --- L3 Lymphocytic Leukemia --- L3 Lymphocytic Leukemias --- Leukemia, Burkitt --- Leukemia, Burkitt Cell --- Leukemia, Burkitt's --- Leukemia, L3 Lymphocytic --- Lymphoma, African --- Lymphoma, Burkitt's --- Tumor, Burkitt --- Tumor, Burkitt's --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- Tumors --- Congresses --- pathogenicity --- Oncology. Neoplasms --- Medical microbiology, virology, parasitology --- Africa --- Cancer, Cervical --- Cervical Cancers
Listing 1 - 7 of 7 |
Sort by
|